PMC:7293470 / 2347-2503 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T79","span":{"begin":21,"end":25},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T80","span":{"begin":73,"end":81},"obj":"CL:0000233;GO:0030168;CHEBI:44811;CHEBI:44811"},{"id":"T81","span":{"begin":81,"end":92},"obj":"GO:0030168;CHEBI:44811;CHEBI:44811"},{"id":"T82","span":{"begin":93,"end":99},"obj":"CHEBI:44811;CHEBI:44811"},{"id":"T83","span":{"begin":104,"end":113},"obj":"CHEBI:18295;CHEBI:18295"},{"id":"T84","span":{"begin":119,"end":128},"obj":"CL:0000097"},{"id":"T70978","span":{"begin":21,"end":25},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T2252","span":{"begin":73,"end":81},"obj":"CL:0000233;GO:0030168;CHEBI:44811;CHEBI:44811"},{"id":"T56269","span":{"begin":81,"end":92},"obj":"GO:0030168;CHEBI:44811;CHEBI:44811"},{"id":"T88762","span":{"begin":93,"end":99},"obj":"CHEBI:44811;CHEBI:44811"},{"id":"T44552","span":{"begin":104,"end":113},"obj":"CHEBI:18295;CHEBI:18295"},{"id":"T96679","span":{"begin":119,"end":128},"obj":"CL:0000097"}],"text":"Another bifunctional drug was formulated to antagonize the receptors for platelet-activating factor and histamine, and mast cell secretion-blocking effects."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T29","span":{"begin":73,"end":81},"obj":"Body_part"},{"id":"T30","span":{"begin":104,"end":113},"obj":"Body_part"},{"id":"T31","span":{"begin":119,"end":128},"obj":"Body_part"},{"id":"T32","span":{"begin":124,"end":128},"obj":"Body_part"}],"attributes":[{"id":"A29","pred":"fma_id","subj":"T29","obj":"http://purl.org/sig/ont/fma/fma62851"},{"id":"A30","pred":"fma_id","subj":"T30","obj":"http://purl.org/sig/ont/fma/fma61806"},{"id":"A31","pred":"fma_id","subj":"T31","obj":"http://purl.org/sig/ont/fma/fma66784"},{"id":"A32","pred":"fma_id","subj":"T32","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Another bifunctional drug was formulated to antagonize the receptors for platelet-activating factor and histamine, and mast cell secretion-blocking effects."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T46","span":{"begin":82,"end":92},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T47","span":{"begin":124,"end":128},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"Another bifunctional drug was formulated to antagonize the receptors for platelet-activating factor and histamine, and mast cell secretion-blocking effects."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T30","span":{"begin":21,"end":25},"obj":"Chemical"},{"id":"T31","span":{"begin":73,"end":99},"obj":"Chemical"},{"id":"T34","span":{"begin":104,"end":113},"obj":"Chemical"}],"attributes":[{"id":"A30","pred":"chebi_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A31","pred":"chebi_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/CHEBI_36707"},{"id":"A32","pred":"chebi_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/CHEBI_44811"},{"id":"A33","pred":"chebi_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/CHEBI_52450"},{"id":"A34","pred":"chebi_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/CHEBI_18295"},{"id":"A35","pred":"chebi_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/CHEBI_58432"}],"text":"Another bifunctional drug was formulated to antagonize the receptors for platelet-activating factor and histamine, and mast cell secretion-blocking effects."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T9","span":{"begin":73,"end":92},"obj":"http://purl.obolibrary.org/obo/GO_0030168"},{"id":"T10","span":{"begin":129,"end":138},"obj":"http://purl.obolibrary.org/obo/GO_0046903"}],"text":"Another bifunctional drug was formulated to antagonize the receptors for platelet-activating factor and histamine, and mast cell secretion-blocking effects."}

{"project":"LitCovid-sentences","denotations":[{"id":"T12","span":{"begin":0,"end":156},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Another bifunctional drug was formulated to antagonize the receptors for platelet-activating factor and histamine, and mast cell secretion-blocking effects."}

{"project":"LitCovid-PubTator","denotations":[{"id":"133","span":{"begin":104,"end":113},"obj":"Chemical"}],"attributes":[{"id":"A133","pred":"tao:has_database_id","subj":"133","obj":"MESH:D006632"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Another bifunctional drug was formulated to antagonize the receptors for platelet-activating factor and histamine, and mast cell secretion-blocking effects."}